Annual Current Assets
$24.65 M
-$30.28 M-55.13%
30 September 2022
Summary:
NeuBase Therapeutics annual total current assets is currently $24.65 million, with the most recent change of -$30.28 million (-55.13%) on 30 September 2022. During the last 3 years, it has fallen by -$30.28 million (-55.13%).NBSE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$13.35 M
-$2.17 M-13.96%
30 September 2023
Summary:
NeuBase Therapeutics quarterly total current assets is currently $13.35 million, with the most recent change of -$2.17 million (-13.96%) on 30 September 2023.NBSE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -55.1% | -75.7% |
| 5 y5 years | +123.5% | +21.1% |
NBSE Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -55.1% | -77.8% |
NeuBase Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $13.35 M(-14.0%) |
| June 2023 | - | $15.52 M(+9.2%) |
| Mar 2023 | - | $14.21 M(-20.9%) |
| Dec 2022 | - | $17.97 M(-27.1%) |
| Sept 2022 | $8.04 M(-12.9%) | $24.65 M(-22.1%) |
| June 2022 | - | $31.62 M(-21.4%) |
| Mar 2022 | - | $40.22 M(-17.0%) |
| Dec 2021 | - | $48.48 M(-11.7%) |
| Sept 2021 | $9.24 M(+464.8%) | $54.93 M(-8.8%) |
| June 2021 | - | $60.22 M(+141.4%) |
| Mar 2021 | - | $24.94 M(-13.5%) |
| Dec 2020 | - | $28.82 M(-12.2%) |
| Sept 2020 | $1.64 M(+8.9%) | $32.81 M(-11.1%) |
| June 2020 | - | $36.89 M(+470.2%) |
| Mar 2020 | - | $6.47 M(-24.2%) |
| Dec 2019 | - | $8.53 M(-22.6%) |
| Sept 2019 | $1.50 M(>+9900.0%) | $11.03 M(+607.9%) |
| June 2019 | - | $1.56 M(-33.2%) |
| Mar 2019 | - | $2.33 M(-27.5%) |
| Dec 2018 | - | $3.21 M(+1187.5%) |
| Sept 2018 | $0.00(-100.0%) | $249.60 K(-94.9%) |
| June 2018 | - | $4.85 M(-16.9%) |
| Mar 2018 | - | $5.84 M(-33.9%) |
| Dec 2017 | - | $8.82 M(-32.2%) |
| Sept 2017 | $14.90 M(-7.8%) | $13.02 M(-29.7%) |
| June 2017 | - | $18.52 M(+83.5%) |
| Mar 2017 | - | $10.09 M(-27.2%) |
| Dec 2016 | - | $13.86 M(+4.3%) |
| Sept 2016 | $16.16 M(-6.8%) | $13.29 M(-25.6%) |
| June 2016 | - | $17.86 M(-20.1%) |
| Mar 2016 | - | $22.34 M(-17.6%) |
| Dec 2015 | - | $27.10 M(-6.7%) |
| Sept 2015 | $17.33 M(-7.2%) | $29.04 M(-8.4%) |
| June 2015 | - | $31.70 M(-5.6%) |
| Mar 2015 | - | $33.59 M(+204.8%) |
| Dec 2014 | - | $11.02 M(-17.5%) |
| Sept 2014 | $18.67 M(+3143.8%) | $13.35 M(-11.5%) |
| June 2014 | - | $15.10 M(+306.8%) |
| Mar 2014 | - | $3.71 M(-8.1%) |
| Dec 2013 | - | $4.04 M(-21.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | $575.60 K(-13.7%) | $5.17 M(-17.4%) |
| June 2013 | - | $6.26 M(+217.2%) |
| Mar 2013 | - | $1.97 M(-13.4%) |
| Dec 2012 | - | $2.28 M(-20.0%) |
| Sept 2012 | $666.80 K(-7.5%) | $2.85 M(+49.4%) |
| June 2012 | - | $1.91 M(+56.9%) |
| Mar 2012 | - | $1.22 M(-9.3%) |
| Dec 2011 | - | $1.34 M(+93.9%) |
| Sept 2011 | $721.10 K(-10.4%) | $691.80 K(-24.0%) |
| June 2011 | - | $910.40 K(-21.6%) |
| Mar 2011 | - | $1.16 M(+43.1%) |
| Dec 2010 | - | $811.30 K(+33.5%) |
| Sept 2010 | $804.60 K(+0.6%) | $607.50 K(-14.7%) |
| June 2010 | - | $712.00 K(-17.1%) |
| Mar 2010 | - | $858.80 K(+52.0%) |
| Dec 2009 | - | $564.90 K(+31.2%) |
| Sept 2009 | $800.00 K(+841.2%) | $430.60 K(-34.3%) |
| June 2009 | - | $655.00 K(+3538.9%) |
| Mar 2009 | - | $18.00 K(-28.0%) |
| Dec 2008 | - | $25.00 K(-73.9%) |
| Sept 2008 | $85.00 K(-83.2%) | $95.80 K(-39.0%) |
| June 2008 | - | $157.00 K(-42.5%) |
| Mar 2008 | - | $273.00 K(+46.8%) |
| Dec 2007 | - | $186.00 K(-5.6%) |
| Sept 2007 | $505.00 K(-5.5%) | $197.00 K(-47.0%) |
| June 2007 | - | $372.00 K(0.0%) |
| Mar 2007 | - | $372.00 K(-0.1%) |
| Dec 2006 | - | $372.30 K(0.0%) |
| Sept 2006 | - | $372.30 K(0.0%) |
| June 2006 | - | $372.30 K(+687.1%) |
| Mar 2006 | - | $47.30 K(+17.4%) |
| Dec 2005 | $534.30 K(+163.3%) | $40.30 K(-89.8%) |
| Sept 2005 | - | $393.20 K(+18.8%) |
| June 2005 | - | $331.00 K(-24.3%) |
| Mar 2005 | - | $437.10 K(+44.6%) |
| Dec 2004 | $202.90 K(+15.9%) | $302.30 K(-23.4%) |
| Sept 2004 | - | $394.70 K(-43.7%) |
| June 2004 | - | $701.30 K(+8349.4%) |
| Mar 2004 | - | $8300.00 |
| Dec 2003 | $175.00 K | - |
FAQ
- What is NeuBase Therapeutics annual total current assets?
- What is the all time high annual current assets for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for NeuBase Therapeutics?
What is NeuBase Therapeutics annual total current assets?
The current annual current assets of NBSE is $24.65 M
What is the all time high annual current assets for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual total current assets is $54.93 M
What is NeuBase Therapeutics quarterly total current assets?
The current quarterly current assets of NBSE is $13.35 M
What is the all time high quarterly current assets for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly total current assets is $60.22 M